SCHEMBL6089806

SCHEMBL6089806

Oc1cccc(CNc2ccc3ccccc3n2)c1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 1/20 0.54
NPC1 O15118 3/20 0.52
RAB9A P51151 3/20 0.52
KDM4E B2RXH2 3/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
HPGD P15428 2/20 0.51
TP53 P04637 1/20 0.51
HTT P42858 1/20 0.51
HSD17B10 Q99714 1/20 0.51
NFKB1 P19838 2/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
PKM P14618 1/20 0.46
ALOX15 P16050 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.45
MAPT P10636 1/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30885179 0.82 RAB9A (0.66) HDAC6NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL19553834 0.82 RAB9A (0.66) HDAC6NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL18572645 0.82 SMN1; SMN2 (0.50) HDAC6NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL14147454 0.77 NLRP3 (0.48) KDM4ENFKB1CYP1A2CYP3A4PKM
SCHEMBL22926769 0.74 NPC1 (0.63) HDAC6NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL14980555 0.74 NPC1 (0.63) HDAC6NPC1RAB9AKDM4ESMN1; SMN2
SCHEMBL15560182 0.73 CYSLTR1 (0.51) OPRK1CYSLTR2CYSLTR1
Hydrochloric Acid SCHEMBL15549877 0.72 CYSLTR1 (0.50) OPRK1CYSLTR2CYSLTR1
SCHEMBL6089769 0.72 CYSLTR1 (0.53) KDM4ESMN1; SMN2HTTCYP3A4KMT2A
SCHEMBL6090056 0.71 ELANE (0.49) HDAC6NPC1RAB9AKDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7005440-B1 Therapeutic uses of tri-aryl acid derivatives AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2006-02-28 US disclosed
EP-1177176-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS Aventis Pharma Deutschland GmbH (DE) 2002-02-06 EP disclosed
WO-2000064876-A1 TRI-ARYL ACID DERIVATIVES AS PPAR RECEPTOR LIGANDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-11-02 WO disclosed